Melanie McPhail

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

Deirdre Weymann, S. Peacock, T. Bubela, 2022, npj Precision Oncology.

Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

T. Bubela, Emma Weiss, Melanie McPhail, 2022, Frontiers in Medicine.

The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in Canada

T. Bubela, D. Regier, C. McCabe, 2022, Healthcare policy = Politiques de sante.

The Constitutionality of Restrictions on Recreational Cannabis Advertising: Balancing Public Health and Freedom of Expression

Melanie McPhail, 2017 .

Freedom of expression litigation and the harms of cannabis

J. Shelley, Melanie McPhail, 2019 .

Lessons from Canada’s notice of compliance with conditions policy for the life-cycle regulation of drugs

T. Bubela, Melanie McPhail, Howard Zhang, 2023, Journal of law and the biosciences.

Should Canada adopt managed access agreements in Canada for expensive drugs?

T. Bubela, Melanie McPhail, 2023, Journal of law and the biosciences.